E380D: a novel point mutation of CYP21 in an HLA-homozygous patient with salt-losing congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Article Details
- CitationCopy to clipboard
Kirby-Keyser L, Porter CC, Donohoue PA
E380D: a novel point mutation of CYP21 in an HLA-homozygous patient with salt-losing congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Hum Mutat. 1997;9(2):181-2.
- PubMed ID
- 9067760 [ View in PubMed]
- Abstract
Not Available